Similar articles for PMID: 19906259

Year	Number of Results
1971	1
1993	1
1998	1
2001	1
2003	1
2004	3
2005	5
2006	10
2007	26
2008	24
2009	84
2010	8
2011	6
2012	8
2013	6
2014	9
2015	3
2016	4
2017	2
2018	1
2019	1
2021	2
2024	0

1

AddNeuroMed--the European collaboration for the discovery of novel biomarkers for Alzheimer's disease.

Lovestone S, Francis P, Kloszewska I, Mecocci P, Simmons A, Soininen H, Spenger C, Tsolaki M, Vellas B, Wahlund LO, Ward M; AddNeuroMed Consortium. Lovestone S, et al. Ann N Y Acad Sci. 2009 Oct;1180:36-46. doi: 10.1111/j.1749-6632.2009.05064.x. Ann N Y Acad Sci. 2009. PMID: 19906259

2

Plasma biomarkers for mild cognitive impairment and Alzheimer's disease.

Song F, Poljak A, Smythe GA, Sachdev P. Song F, et al. Brain Res Rev. 2009 Oct;61(2):69-80. doi: 10.1016/j.brainresrev.2009.05.003. Epub 2009 May 21. Brain Res Rev. 2009. PMID: 19464319 Review.

3

Biomarkers for Alzheimer's disease.

Sonnen JA, Keene CD, Montine KS, Li G, Peskind ER, Zhang J, Montine TJ. Sonnen JA, et al. Expert Rev Neurother. 2007 Aug;7(8):1021-8. doi: 10.1586/14737175.7.8.1021. Expert Rev Neurother. 2007. PMID: 17678497 Review.

4

Biomarkers for Alzheimer's disease.

Ward M. Ward M. Expert Rev Mol Diagn. 2007 Sep;7(5):635-46. doi: 10.1586/14737159.7.5.635. Expert Rev Mol Diagn. 2007. PMID: 17892369 Review.

5

Biomarkers in Alzheimer's disease: not yet surrogate endpoints.

Coley N, Andrieu S, Delrieu J, Voisin T, Vellas B. Coley N, et al. Ann N Y Acad Sci. 2009 Oct;1180:119-24. doi: 10.1111/j.1749-6632.2009.04947.x. Ann N Y Acad Sci. 2009. PMID: 19906266

6

Methodology for discovery of Alzheimer's disease blood-based biomarkers.

Maes OC, Schipper HM, Chertkow HM, Wang E. Maes OC, et al. J Gerontol A Biol Sci Med Sci. 2009 Jun;64(6):636-45. doi: 10.1093/gerona/glp045. Epub 2009 Apr 14. J Gerontol A Biol Sci Med Sci. 2009. PMID: 19366883

7

Biomarkers for disease modification trials--the innovative medicines initiative and AddNeuroMed.

Lovestone S, Francis P, Strandgaard K. Lovestone S, et al. J Nutr Health Aging. 2007 Jul-Aug;11(4):359-61. J Nutr Health Aging. 2007. PMID: 17653500 Review. No abstract available.

8

Disease-modifying approaches to Alzheimer's disease: challenges and opportunities-Lessons from donepezil therapy.

Sabbagh MN, Richardson S, Relkin N. Sabbagh MN, et al. Alzheimers Dement. 2008 Jan;4(1 Suppl 1):S109-18. doi: 10.1016/j.jalz.2007.11.013. Alzheimers Dement. 2008. PMID: 18631986 Review.

9

Serum biomarkers for Alzheimer's disease: proteomic discovery.

German DC, Gurnani P, Nandi A, Garner HR, Fisher W, Diaz-Arrastia R, O'Suilleabhain P, Rosenblatt KP. German DC, et al. Biomed Pharmacother. 2007 Aug;61(7):383-9. doi: 10.1016/j.biopha.2007.05.009. Epub 2007 Jun 18. Biomed Pharmacother. 2007. PMID: 17614251

10

Proteomics of Alzheimer's disease: understanding mechanisms and seeking biomarkers.

Lovestone S, Güntert A, Hye A, Lynham S, Thambisetty M, Ward M. Lovestone S, et al. Expert Rev Proteomics. 2007 Apr;4(2):227-38. doi: 10.1586/14789450.4.2.227. Expert Rev Proteomics. 2007. PMID: 17425458 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

193 results

Results by year